| Term 
 | Definition 
 
        | Hypersensitivity reactions |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Peripheral Neuropathy Pancreatitis
 Take on empty stomach
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Peripheral neuropathy Pancreatitis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Decreased bone marrow density Renal Dysfunction (Faconi Syndrome)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hepatotoxcity Infection
 Malignancy
 Tropoism Testing
 CYP3A4 substrate only
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SQ admin - local injection site rxn Broken down in blood
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lactic acidosis Severe hepatomegaly with steatosis
 TEAL have least risk
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CNS problem - empty stomach QHS Rash
 Pregnancy category D
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rash Hepatotoxicity (do not give if CD4 > 250 in females, >400 in males)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rash Do not need renal adjustment
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Myopathy/CPK elevation Rash
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Decreased bone marrow density Only in combo Stribild (emtricitabine, tenofovir, and cobicistat - inhibit 3A4 for increased levels)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hypersensitivity (rash) Must increase to BID dosing if given with potent UGT or 3A4 inducer or integrase inhibitor resistance mutations
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect hyperbilirubinemia Nephrolithiasis
 Prolonged PR interval
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Rash (sulfa allergy) Always given with ritonavir
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nephrolithiasis Give on empty stomach
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Kaletra GI intolerance
 Prolonged PR/QT interval
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Only given as PK booster Parsthesias
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | With Food Always with ritonavir
 Prlonged PR/QT interval
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Always with ritonavir With Food
 Increased LFTs
 Rash
 Rare intracranial hemorrhag
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hyperglycemia Fat maldistribution
 Lipid abnormalities
 Increased bleeding episodes
 (Metabolic syndrome)
 AFI drugs - adequate hydration
 |  | 
        |  | 
        
        | Term 
 
        | Drugs not to use with rifampin |  | Definition 
 
        | Nevirapine Etravirine
 Rilpivirine
 Maraviroc
 Elvitegravir/Cobicistat
 |  | 
        |  | 
        
        | Term 
 
        | Drugs that interact with warfarin |  | Definition 
 
        | Efavirenz Nevirapine
 Etravirine?
 Elvitegravir/Cobicistat
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Co-trimoxazole/Ganciclovir Possible synergistic bone marrow toxicity
 |  | 
        |  |